HR 10150 · 119th Congress
Advancing Botanical Drug Development Act of 2026
This bill creates a new incentive to encourage pharmaceutical companies to develop drugs made from plants and natural botanical sources. Right now, companies that develop traditional synthetic drugs get 12 years of market exclusivity—meaning competitors can't make generic versions during that time. However, botanica…
- Sponsor
- Boebert, Lauren (R-Colorado)
- Introduced
- 2026-08-27
- Policy area
- Health
Digging through Congress... 🔍